Coleman CM - Search Results

1

Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients.

Funnell SGP, Dowling WE, Muñoz-Fontela C, Gsell PS, Ingber DE, Hamilton GA, Delang L, Rocha-Pereira J, Kaptein S, Dallmeier KH, Neyts J, Rosenke K, de Wit E, Feldmann H, Maisonnasse P, Le Grand R, Frieman MB, Coleman CM. Funnell SGP, et al. Among authors: coleman cm. Nat Commun. 2020 Aug 26;11(1):4253. doi: 10.1038/s41467-020-17907-w. Nat Commun. 2020. PMID: 32848158 Free PMC article.

2

Coronaviruses: important emerging human pathogens.

Coleman CM, Frieman MB. Coleman CM, et al. J Virol. 2014 May;88(10):5209-12. doi: 10.1128/JVI.03488-13. Epub 2014 Mar 5. J Virol. 2014. PMID: 24600003 Free PMC article. Review.

3

Treating MERS-CoV during an outbreak.

Coleman CM, Frieman MB. Coleman CM, et al. Lancet Infect Dis. 2014 Nov;14(11):1030-1031. doi: 10.1016/S1473-3099(14)70939-9. Epub 2014 Sep 29. Lancet Infect Dis. 2014. PMID: 25278219 Free PMC article. No abstract available.

4

Growth and Quantification of MERS-CoV Infection.

Coleman CM, Frieman MB. Coleman CM, et al. Curr Protoc Microbiol. 2015 May 1;37(1):15E.2.1-9. doi: 10.1002/9780471729259.mc15e02s37. Curr Protoc Microbiol. 2015. PMID: 26344219 Free PMC article.

5

Emergence of the Middle East respiratory syndrome coronavirus.

Coleman CM, Frieman MB. Coleman CM, et al. PLoS Pathog. 2013;9(9):e1003595. doi: 10.1371/journal.ppat.1003595. Epub 2013 Sep 5. PLoS Pathog. 2013. PMID: 24039577 Free PMC article. Review. No abstract available.

6

Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus.

Coleman CM, Matthews KL, Goicochea L, Frieman MB. Coleman CM, et al. J Gen Virol. 2014 Feb;95(Pt 2):408-412. doi: 10.1099/vir.0.060640-0. Epub 2013 Nov 6. J Gen Virol. 2014. PMID: 24197535 Free PMC article.

7

Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.

Venkataraman T, Coleman CM, Frieman MB. Venkataraman T, et al. Among authors: coleman cm. J Virol. 2017 May 26;91(12):e00182-17. doi: 10.1128/JVI.00182-17. Print 2017 Jun 15. J Virol. 2017. PMID: 28404843 Free PMC article.

8

Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo.

Weston S, Coleman CM, Haupt R, Logue J, Matthews K, Li Y, Reyes HM, Weiss SR, Frieman MB. Weston S, et al. Among authors: coleman cm. J Virol. 2020 Oct 14;94(21):e01218-20. doi: 10.1128/JVI.01218-20. Print 2020 Oct 14. J Virol. 2020. PMID: 32817221 Free PMC article.

9

Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection.

Kulcsar KA, Coleman CM, Beck SE, Frieman MB. Kulcsar KA, et al. Among authors: coleman cm. JCI Insight. 2019 Oct 17;4(20):e131774. doi: 10.1172/jci.insight.131774. JCI Insight. 2019. PMID: 31550243 Free PMC article.

10

Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.

Coleman CM, Sisk JM, Mingo RM, Nelson EA, White JM, Frieman MB. Coleman CM, et al. J Virol. 2016 Sep 12;90(19):8924-33. doi: 10.1128/JVI.01429-16. Print 2016 Oct 1. J Virol. 2016. PMID: 27466418 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page